title: Investigation of the essential role of platelet-tumor cell interactions in metastasis progression using an agent-based model.
abstract: BACKGROUND
  Metastatic tumors are a major source of morbidity and mortality for most cancers. Interaction of circulating tumor cells with endothelium, platelets and neutrophils play an important role in the early stages of metastasis formation. These complex dynamics have proven difficult to study in experimental models. Prior computational models of metastases have focused on tumor cell growth in a host environment, or prediction of metastasis formation from clinical data. We used agent-based modeling (ABM) to dynamically represent hypotheses of essential steps involved in circulating tumor cell adhesion and interaction with other circulating cells, examine their functional constraints, and predict effects of inhibiting specific mechanisms.
  
  
  METHODS
  We developed an ABM of Early Metastasis (ABMEM), a descriptive semi-mechanistic model that replicates experimentally observed behaviors of populations of circulating tumor cells, neutrophils, platelets and endothelial cells while incorporating representations of known surface receptor, autocrine and paracrine interactions. Essential downstream cellular processes were incorporated to simulate activation in response to stimuli, and calibrated with experimental data. The ABMEM was used to identify potential points of interdiction through examination of dynamic outcomes such as rate of tumor cell binding after inhibition of specific platelet or tumor receptors.
  
  
  RESULTS
  The ABMEM reproduced experimental data concerning neutrophil rolling over endothelial cells, inflammation-induced binding between neutrophils and platelets, and tumor cell interactions with these cells. Simulated platelet inhibition with anti-platelet drugs produced unstable aggregates with frequent detachment and re-binding. The ABMEM replicates findings from experimental models of circulating tumor cell adhesion, and suggests platelets play a critical role in this pre-requisite for metastasis formation. Similar effects were observed with inhibition of tumor integrin αV/β3. These findings suggest that anti-platelet or anti-integrin therapies may decrease metastasis by preventing stable circulating tumor cell adhesion.
  
  
  CONCLUSIONS
  Circulating tumor cell adhesion is a complex, dynamic process involving multiple cell-cell interactions. The ABMEM successfully captures the essential interactions necessary for this process, and allows for in-silico iterative characterization and invalidation of proposed hypotheses regarding this process in conjunction with in-vitro and in-vivo models. Our results suggest that anti-platelet therapies and anti-integrin therapies may play a promising role in inhibiting metastasis formation.
authors.forename: Abhineet
authors.initials: A
authors.lastname: Uppal
authors.forename: Sean C
authors.initials: SC
authors.lastname: Wightman
authors.forename: Sabha
authors.initials: S
authors.lastname: Ganai
authors.forename: Ralph R
authors.initials: RR
authors.lastname: Weichselbaum
authors.affiliation: Department of Surgery, The University of Chicago Medicine, 5841 S, Maryland Avenue, MC 5094 S-032, Chicago, IL 60637, USA. docgca@gmail.com.
authors.forename: Gary
authors.initials: G
authors.lastname: An
mesh_terms: D001792:Blood Platelets / Q000473:pathology*; D002448:Cell Adhesion; D006801:Humans; D008962:Models, Theoretical; D009362:Neoplasm Metastasis; D009369:Neoplasms / Q000473:pathology*; D009360:Neoplastic Cells, Circulating / Q000473:pathology; D009504:Neutrophils / Q000473:pathology
references.citation: Am J Physiol Cell Physiol. 2001 Apr;280(4):C814-22
references.pmid: 11245598
references.citation: Endocr Rev. 2007 May;28(3):297-321
references.pmid: 17409287
references.citation: Cardiovasc Res. 1995 Nov;30(5):676-81
references.pmid: 8595612
references.citation: Front Oncol. 2013 Mar 05;3:44
references.pmid: 23467856
references.citation: PLoS Comput Biol. 2008 Apr 25;4(4):e1000014
references.pmid: 18437239
references.citation: Cancer Res. 2006 Feb 1;66(3):1597-604
references.pmid: 16452218
references.citation: Cancer Prev Res (Phila). 2012 Feb;5(2):266-75
references.pmid: 21930797
references.citation: Blood. 1994 May 1;83(9):2669-77
references.pmid: 7513210
references.citation: Jpn J Cancer Res. 2002 Oct;93(10):1175-81
references.pmid: 12417048
references.citation: Cell Mol Bioeng. 2008 Sep 1;1(2-3):189-200
references.pmid: 19865613
references.citation: PLoS One. 2011;6(11):e24808
references.pmid: 22110576
references.citation: Clin Immunol Immunopathol. 1988 Jun;47(3):296-309
references.pmid: 2836117
references.citation: J Biol Chem. 2012 Jan 13;287(3):2168-78
references.pmid: 22102277
references.citation: Microcirculation. 2009 Jan;16(1):31-42
references.pmid: 19037827
references.citation: Biochem J. 2011 Jun 1;436(2):469-80
references.pmid: 21391917
references.citation: Invest New Drugs. 2011 Dec;29(6):1432-40
references.pmid: 20336348
references.citation: J Thromb Haemost. 2013 Jun;11(6):1172-82
references.pmid: 23581432
references.citation: Thromb Haemost. 1995 Jul;74(1):282-90
references.pmid: 8578473
references.citation: J Biol Chem. 1998 Jan 23;273(4):2030-4
references.pmid: 9442040
references.citation: J Clin Invest. 1993 Dec;92(6):3038-44
references.pmid: 7504697
references.citation: J Biolumin Chemilumin. 1989 Apr-Jun;3(2):93-6
references.pmid: 2728918
references.citation: Proc Natl Acad Sci U S A. 2001 Feb 13;98(4):1853-8
references.pmid: 11172040
references.citation: Nat Rev Cancer. 2011 Feb;11(2):123-34
references.pmid: 21258396
references.citation: Am J Physiol. 1999 Jun;276(6):H1943-50
references.pmid: 10362674
references.citation: J Immunol. 2011 Jan 1;186(1):242-54
references.pmid: 21135163
references.citation: Clin Cancer Res. 2004 Oct 15;10(20):6897-904
references.pmid: 15501967
references.citation: Cardiovasc Res. 1996 Oct;32(4):743-51
references.pmid: 8915192
references.citation: Exp Cell Res. 2010 Jan 1;316(1):138-48
references.pmid: 19747913
references.citation: BMC Cancer. 2010 Apr 30;10:177
references.pmid: 20433713
references.citation: EMBO Mol Med. 2012 Nov;4(11):1156-75
references.pmid: 23070965
references.citation: Blood. 2011 Sep 8;118(10):2889-95
references.pmid: 21788337
references.citation: J Biol Chem. 2005 Nov 4;280(44):37021-32
references.pmid: 16115878
references.citation: J Biol Chem. 2001 Feb 16;276(7):4692-8
references.pmid: 11084032
references.citation: Cytometry A. 2010 Oct;77(10):962-70
references.pmid: 21290470
references.citation: J Biol Chem. 2011 Oct 7;286(40):34777-87
references.pmid: 21840991
references.citation: Thromb Haemost. 1983 Oct 31;50(3):726-30
references.pmid: 6648893
references.citation: Thromb Haemost. 2003 Aug;90(2):299-308
references.pmid: 12888878
references.citation: Jpn J Clin Oncol. 2011 Aug;41(8):937-47
references.pmid: 21743066
references.citation: Res Exp Med (Berl). 1995;195(4):209-15
references.pmid: 8525071
references.citation: J Biol Chem. 2006 Sep 8;281(36):26665-74
references.pmid: 16837456
references.citation: Arq Bras Cardiol. 2008 Jan;90(1):54-63
references.pmid: 18317641
references.citation: Curr Opin Genet Dev. 2010 Feb;20(1):96-9
references.pmid: 20071161
references.citation: Cancer Res. 2006 Aug 1;66(15):7766-74
references.pmid: 16885380
references.citation: J Clin Bioinforma. 2012 Jul 05;2(1):11
references.pmid: 22548735
references.citation: Cell. 2012 Jan 20;148(1-2):362-75
references.pmid: 22265421
references.citation: Arterioscler Thromb Vasc Biol. 2001 Oct;21(10):1585-91
references.pmid: 11597930
references.citation: Am J Pathol. 2001 Feb;158(2):639-46
references.pmid: 11159200
references.citation: Breast Cancer Res Treat. 2008 Nov;112(2):243-54
references.pmid: 18097747
references.citation: Blood. 2002 Jan 1;99(1):193-8
references.pmid: 11756171
references.citation: Thromb Res. 2012 Jun;129(6):779-86
references.pmid: 21917301
references.citation: J Clin Invest. 1998 Oct 15;102(8):1526-33
references.pmid: 9788965
references.citation: PLoS One. 2012;7(4):e34637
references.pmid: 22558094
references.citation: PLoS One. 2013;8(2):e55688
references.pmid: 23405196
references.citation: Circ Res. 2000 Aug 4;87(3):179-83
references.pmid: 10926866
references.citation: J Immunol. 1998 Aug 15;161(4):1921-9
references.pmid: 9712062
references.citation: Cancer Biother Radiopharm. 2000 Feb;15(1):71-9
references.pmid: 10740655
references.citation: J Exp Med. 1998 Feb 2;187(3):329-39
references.pmid: 9449713
references.citation: J Gastrointest Surg. 2004 Dec;8(8):1049-59; discussion 1060
references.pmid: 15585393
references.citation: Sci Transl Med. 2010 Jul 21;2(41):41ps34
references.pmid: 20650869
references.citation: Anticancer Res. 2007 Jan-Feb;27(1A):17-22
references.pmid: 17352210
references.citation: Semin Immunopathol. 2012 Jan;34(1):93-106
references.pmid: 21845431
references.citation: Int J Cancer. 2009 Nov 1;125(9):2058-65
references.pmid: 19598263
references.citation: Ann Oncol. 2013 Feb;24(2):329-336
references.pmid: 23104724
references.citation: Lancet. 2012 Apr 28;379(9826):1591-601
references.pmid: 22440947
references.citation: J Biol Chem. 2000 Aug 18;275(33):25216-21
references.pmid: 10837487
references.citation: Prog Lipid Res. 2003 Sep;42(5):423-38
references.pmid: 12814644
references.citation: Theor Biol Med Model. 2008 May 27;5:11
references.pmid: 18505587
references.citation: J Biol Chem. 2007 Feb 16;282(7):4812-4820
references.pmid: 17172469
references.citation: Mol Cell Biochem. 2012 Apr;363(1-2):269-80
references.pmid: 22198289
references.citation: Cancer Res. 2010 Jul 15;70(14):6071-82
references.pmid: 20610626
references.citation: J Thromb Haemost. 2004 Mar;2(3):476-84
references.pmid: 15009466
references.citation: Comput Methods Biomech Biomed Engin. 2015;18(3):282-92
references.pmid: 23656190
references.citation: J Leukoc Biol. 1991 Jan;49(1):83-9
references.pmid: 1845813
references.citation: Shock. 2009 Feb;31(2):120-4
references.pmid: 18636042
references.citation: Invest New Drugs. 2013 Feb;31(1):175-82
references.pmid: 22752690
references.citation: Biochemistry. 2000 May 9;39(18):5458-67
references.pmid: 10820018
references.citation: Cell Mol Life Sci. 2007 Dec;64(24):3306-16
references.pmid: 17994288
references.citation: J Cell Biol. 2004 Mar 15;164(6):935-41
references.pmid: 15024036
references.citation: Blood. 2001 Jul 1;98(1):108-16
references.pmid: 11418469
references.citation: Eur J Cancer. 2005 May;41(7):1065-72
references.pmid: 15862757
references.citation: Endothelium. 1998;6(2):113-21
references.pmid: 9930645
references.citation: Blood. 2012 Sep 6;120(10):2133-43
references.pmid: 22837532
references.citation: Nat Rev Cancer. 2010 Jan;10(1):9-22
references.pmid: 20029421
references.citation: J Natl Cancer Inst. 2009 Feb 18;101(4):256-66
references.pmid: 19211452
references.citation: J Cell Sci. 1995 Sep;108 ( Pt 9):3059-66
references.pmid: 8537445
references.citation: Thromb Haemost. 2007 Aug;98(2):283-6
references.pmid: 17721608
references.citation: Clin Exp Metastasis. 2004;21(6):553-61
references.pmid: 15679053
references.citation: J Cell Physiol. 1993 Aug;156(2):428-36
references.pmid: 8344997
references.citation: Cancer Res. 2011 Nov 1;71(21):6561-6
references.pmid: 22009534
references.citation: Semin Radiat Oncol. 2006 Apr;16(2):111-9
references.pmid: 16564446
references.citation: Drug Metab Dispos. 2011 Oct;39(10):1910-20
references.pmid: 21768275
references.citation: Am J Respir Cell Mol Biol. 1998 Jan;18(1):100-10
references.pmid: 9448051
references.citation: Blood. 1997 Mar 15;89(6):2131-8
references.pmid: 9058736
references.citation: Thromb Res. 1979;15(1-2):209-13
references.pmid: 384596
references.citation: Int J Cancer. 1985 Jan 15;35(1):121-7
references.pmid: 3917986
references.citation: Br J Cancer. 2013 Oct 1;109(7):1921-5
references.pmid: 23887604
references.citation: Cancer Res. 2012 Aug 15;72(16):3919-27
references.pmid: 22751466
references.citation: J Cell Physiol. 2012 Feb;227(2):431-8
references.pmid: 21465465
references.citation: J Clin Invest. 1992 Sep;90(3):1116-21
references.pmid: 1325992
references.citation: Circ Res. 1994 Jun;74(6):1133-40
references.pmid: 7910528
references.citation: Cancer Res. 2012 Sep 15;72(18):4662-71
references.pmid: 22836751
references.citation: Br J Cancer. 2012 May 22;106(11):1833-41
references.pmid: 22617157
references.citation: Clin Cancer Res. 2008 Nov 1;14(21):6735-41
references.pmid: 18980965
references.citation: J Theor Biol. 2006 Dec 7;243(3):407-17
references.pmid: 16930629
references.citation: J Invest Dermatol. 2010 Sep;130(9):2259-68
references.pmid: 20505748
references.citation: J Exp Med. 1995 Jun 1;181(6):2259-64
references.pmid: 7539045
references.citation: J Neurooncol. 2012 Oct;110(1):27-36
references.pmid: 22842979
references.citation: Int J Cancer. 2011 May 1;128(9):2038-49
references.pmid: 20648559
references.citation: J Biomed Biotechnol. 2009;2009:829243
references.pmid: 19888429
references.citation: BMC Bioinformatics. 2010 Oct 15;11 Suppl 7:S13
references.pmid: 21106120
references.citation: Cancer Res. 2010 Jul 15;70(14):5649-69
references.pmid: 20610625
references.citation: Proc Natl Acad Sci U S A. 1991 Jun 1;88(11):4651-5
references.pmid: 1675786
references.citation: Am J Physiol Cell Physiol. 2012 Apr 15;302(8):C1189-201
references.pmid: 22262064
references.citation: Arch Biochem Biophys. 2002 Jan 15;397(2):342-4
references.pmid: 11795892
references.citation: Angiogenesis. 2005;8(1):63-71
references.pmid: 16132619
references.citation: PLoS One. 2011 Apr 27;6(4):e17933
references.pmid: 21556134
references.citation: Arterioscler Thromb Vasc Biol. 2002 May 1;22(5):861-6
references.pmid: 12006403
references.citation: Int J Cancer. 1987 Oct 15;40(4):525-31
references.pmid: 3666990
references.citation: Eur J Clin Pharmacol. 1984;27(2):165-8
references.pmid: 6499897
references.citation: Arterioscler Thromb Vasc Biol. 2005 Jul;25(7):1499-505
references.pmid: 15845904
references.citation: Immunology. 1993 Aug;79(4):608-15
references.pmid: 8406585
references.citation: Clin Exp Metastasis. 2002;19(8):717-25
references.pmid: 12553378
references.citation: Theor Biol Med Model. 2012 Jul 28;9:31
references.pmid: 22838395
references.citation: PLoS One. 2012;7(9):e44281
references.pmid: 23028513
references.citation: Exp Cell Res. 2005 Nov 1;310(2):282-92
references.pmid: 16154563
references.citation: J Immunol. 1999 Nov 1;163(9):5029-38
references.pmid: 10528208
references.citation: Math Biosci. 2010 Feb;223(2):133-41
references.pmid: 19932124
references.citation: J Immunol. 2001 Oct 1;167(7):4017-25
references.pmid: 11564821
references.citation: Int J Cancer. 2004 Jun 20;110(3):326-35
references.pmid: 15095296
references.citation: Platelets. 2012;23(5):368-75
references.pmid: 22671289
references.citation: J R Soc Interface. 2012 Jul 7;9(72):1576-88
references.pmid: 22219399
references.citation: Br J Haematol. 2013 Aug;162(4):433-41
references.pmid: 23691951
references.citation: J Theor Biol. 2006 Jun 21;240(4):521-30
references.pmid: 16343545
references.citation: Nature. 1995 Apr 6;374(6522):539-42
references.pmid: 7535385
references.citation: Blood. 1998 Feb 15;91(4):1318-24
references.pmid: 9454762
references.citation: Cancer Res. 2003 May 1;63(9):2079-87
references.pmid: 12727823